SoftBank Vision Fund entities disclose 2.3% Roivant (ROIV) ownership in 13G/A
Rhea-AI Filing Summary
Roivant Sciences Ltd. received an amended ownership report from SoftBank-affiliated entities. The filing shows that SB Investment Advisers (UK) Limited, SoftBank Vision Fund L.P., SVF Holdings (UK) LLP and SVF Investments (UK) Limited together beneficially own 16,413,603 common shares, representing 2.3% of Roivant’s outstanding stock.
SVF Investments (UK) Limited is the record holder of these shares, and the other SoftBank entities may be deemed to share voting and investment power through their control structure. The ownership is calculated based on 715,701,137 common shares outstanding as of February 2, 2026 and is now reported as 5% or less of the class.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership stake in Roivant Sciences (ROIV) do the SoftBank entities report?
The SoftBank-affiliated entities report beneficial ownership of 16,413,603 Roivant common shares, equal to 2.3% of the outstanding class. This stake is calculated using 715,701,137 common shares outstanding as of February 2, 2026, as disclosed by Roivant.
What percentage of Roivant Sciences (ROIV) does SoftBank report owning in this Schedule 13G/A?
SoftBank-affiliated reporting persons state they beneficially own 2.3% of Roivant’s common shares. This percentage is based on 715,701,137 common shares outstanding as of February 2, 2026, as referenced from Roivant’s Form 10-K, and reflects ownership of 5% or less of the class.
As of what dates are the SoftBank ownership figures in Roivant (ROIV) calculated?
Beneficial ownership reflects holdings as of December 31, 2025, while the percentage calculation uses 715,701,137 common shares outstanding as of February 2, 2026, as disclosed in Roivant’s Form 10-K filed with the SEC on February 6, 2026.